The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Antimicrobial strategies for urinary catheters
Abstract
Over 75% of hospital‐acquired or nosocomial urinary tract infections are initiated by urinary catheters, which are used during the treatment of 16% of hospitalized patients. Taking the United States as an example, the costs of catheter‐associated urinary tract infections (CAUTI) are in excess of $451 million dollars/year. The biofilm formation by pathogenic microbes that protects pathogens from host immune defense and antimicrobial agents is the leading cause for CAUTI. Thus, tremendous efforts have been devoted to antimicrobial coating for urinary catheters in the past few decades, and it has been demonstrated to be one of the most direct and efficient strategies to reduce infections. In this article, we briefly summarize the current methods for preparation of antimicrobial coatings based on different stages in the biofilm formation, highlight recent progress in the urinary catheter coating material design and selection, discuss approaches to improving their long‐term antimicrobial efficacy, biocompatibility, multidrug resistance and recurrent infections, and finally outline future requirements and prospects in antimicrobial coating material design. The scope of the works surveyed is confined to antimicrobial urinary catheters. © 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 107A: 445–467, 2019.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“most of the developed coatings exhibit low biocompatibility and toxicity for human cells [15], and their antimicrobial efficacy has not been completely proven.”
From Development of Chitosan-Based Surfaces to Prevent Single- and Dual-Species Biofilms of Staphylococcus aureus and Pseudomonas aeruginosa (2021) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
Brogden, K. A. (2005) · Nature Reviews Microbiology · doi:10.1038/nrmicro1098 · Cited by 5,829
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396
Extracellular DNA Required for Bacterial Biofilm Formation
Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C., & Mattick, J. S. (2002) · Science · doi:10.1126/science.295.5559.1487 · Cited by 2,203
Persister cells, dormancy and infectious disease
Lewis, K. (2007) · Nature Reviews Microbiology · doi:10.1038/nrmicro1557 · Cited by 2,052
Izano, E. A., Amarante, M. A., Kher, W. B., & Kaplan, J. B. (2008) · Applied and Environmental Microbiology · doi:10.1128/aem.02073-07 · Cited by 553
Kaplan, J. B., Ragunath, C., Ramasubbu, N., & Fine, D. H. (2003) · Journal of Bacteriology · doi:10.1128/jb.185.16.4693-4698.2003 · Cited by 364
DNase Inhibits Gardnerella vaginalis Biofilms In Vitro and In Vivo
Hymes, S. R., Randis, T. M., Sun, T. Y., & Ratner, A. J. (2013) · The Journal of Infectious Diseases · doi:10.1093/infdis/jit047 · Cited by 96
Colletta, A., Wu, J., Wo, Y., Kappler, M., Chen, H., Xi, C., & Meyerhoff, M. E. (2015) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5b00032 · Cited by 89
Research works printed but not linked: 156
- Dwivedi P, 2013, Application of polymer nanocomposites in the nanomedicine landscape: envisaging strategies to combat implant associated infections, J Appl Biomater Funct Mater, 11, 129
- 10.1016/S0924-8579(00)00359-9 · DOI · Paper page
- 10.1086/651091 · DOI · Paper page
- 10.1016/S0002-9343(02)01054-9 · DOI · Paper page
- 10.1086/501675 · DOI
- 10.1038/nrmicro2415 · DOI · Paper page
- 10.1016/j.biotechadv.2010.08.001 · DOI · Paper page
- 10.1099/00221287-146-3-547 · DOI · Paper page
- 10.3389/fcimb.2012.00062 · DOI
- 10.1146/annurev.micro.56.012302.160705 · DOI · Paper page
- Berkeley R, 1980, Microbial adhesion to surfaces, 47 p
- Jarrell K, 2009, Pili and Flagella: Current Research and Future Trends, 215 p
- 10.1016/S0927-7765(00)00213-7 · DOI
- 10.1111/j.1472-765X.2010.02842.x · DOI
- 10.1002/(SICI)1097-4636(199823)43:3<338::AID-JBM16>3.0.CO;2-B · DOI · Paper page
- 10.1128/jb.169.6.2769-2773.1987 · DOI · Paper page
- 10.1016/S0168-1605(98)00060-9 · DOI · Paper page
- 10.1016/S0958-1669(02)00318-X · DOI · Paper page
- 10.1128/CMR.15.2.155-166.2002 · DOI · Paper page
- 10.1128/MMBR.64.4.847-867.2000 · DOI · Paper page
- 10.1128/IAI.58.9.2906-2911.1990 · DOI
- 10.1128/MMBR.60.1.151-166.1996 · doi:10.1128/mmbr.60.1.151-166.1996 · Paper page
- 10.1016/j.pnsc.2008.04.001 · DOI · Paper page
- 10.1146/annurev.med.59.110106.132000 · DOI · Paper page
- 10.1016/j.actbio.2016.11.070 · DOI · Paper page
- 10.1039/C6TB03280J · DOI · Paper page
- 10.1016/j.snb.2017.02.122 · DOI
- 10.1016/j.jhin.2004.11.014 · DOI · Paper page
- Lederer JW, 2014, Multicenter cohort study to assess the impact of a silver‐alloy and hydrogel‐coated urinary catheter on symptomatic catheter‐associated urinary tract infections, Contemp Nurse, 41, 473
- 10.3109/00365599.2011.560007 · DOI
- 10.1016/j.juro.2010.07.036 · DOI
- Stenzelius K, 2016, Catheter‐associated urinary tract infections and other infections in patients hospitalized for acute stroke: A prospective cohort study of two different silicone catheters, Scand J Urol Nephrol, 50, 483
- 10.1002/adhm.201700435 · doi:10.1002/adhm.201700435
- 10.1371/journal.pone.0181363 · DOI · Paper page
- 10.1016/j.actbio.2017.05.048 · DOI
- 10.1002/jbm.a.35929 · DOI
- 10.1038/srep23238 · DOI
- 10.1021/acsami.5b09730 · DOI
- 10.1021/acsami.5b09738 · doi:10.1021/acsami.5b09738
- 10.1021/acsbiomaterials.5b00338 · DOI
- 10.1002/jbm.b.33230 · DOI
- 10.1002/jbm.b.33106 · doi:10.1002/jbm.b.33106
- 10.1016/j.biomaterials.2014.02.033 · DOI
- 10.1016/j.jcis.2004.02.012 · DOI · Paper page
- 10.1016/j.nano.2006.12.001 · DOI · Paper page
- 10.1039/c2bm00155a · DOI
- 10.1088/0957-4484/25/32/325101 · DOI
- Honda M, 2013, In vitro and in vivo antimicrobial properties of silver‐containing hydroxyapatite prepared via ultrasonic spray pyrolysis route, Korean J Couns Psychother, 33, 5008
- 10.1016/j.ccr.2017.11.019 · DOI · Paper page
- 10.1007/s12274-013-0395-6 · DOI · Paper page
- 10.1038/am.2013.3 · DOI · Paper page
- 10.1163/156856203322381447 · DOI
- 10.1163/156856203322381438 · doi:10.1163/156856203322381438
- 10.1002/jbm.b.32755 · doi:10.1002/jbm.b.32755
- 10.1128/AAC.39.11.2397 · DOI · Paper page
- 10.1016/S0140-6736(12)61380-4 · DOI · Paper page
- 10.1016/j.jconrel.2015.01.037 · DOI · Paper page
- 10.1016/j.ijantimicag.2014.06.016 · DOI
- 10.1002/jbm.b.33491 · DOI
- 10.1039/C5TB00671F · DOI
- 10.1016/j.enzmictec.2012.01.006 · DOI
- 10.1128/AAC.50.4.1268-1275.2006 · DOI · Paper page
- 10.1128/AAC.03786-14 · DOI
- 10.1039/C7TB01302G · DOI
- 10.1016/j.bbamem.2008.10.005 · doi:10.1016/j.bbamem.2008.10.005
- 10.1021/bi00010a034 · DOI · Paper page
- 10.1016/j.tibtech.2011.05.001 · DOI · Paper page
- 10.1098/rsbl.2011.1203 · DOI
- 10.1016/j.peptides.2007.10.001 · doi:10.1016/j.peptides.2007.10.001
- 10.1016/j.actbio.2014.12.015 · DOI · Paper page
- 10.1039/c3tb21300e · DOI
- 10.1016/j.actbio.2013.09.009 · DOI
- 10.1002/adhm.201600757 · doi:10.1002/adhm.201600757
- 10.1128/AAC.01254-08 · DOI · Paper page
- 10.1039/c3tb20805b · DOI
- 10.1016/j.biomaterials.2009.07.003 · DOI
- 10.1021/la701067r · DOI · Paper page
- 10.1021/acsnano.5b02067 · DOI · Paper page
- 10.1021/nl063020t · doi:10.1021/nl063020t
- 10.1021/nn101390x · DOI · Paper page
- 10.1039/c1cc11877c · DOI · Paper page
- 10.1021/acsnano.6b05692 · DOI
- 10.1021/la010552a · DOI · Paper page
- 10.1016/j.biomaterials.2007.05.041 · DOI · Paper page
- 10.1016/S0142-9612(97)00245-7 · DOI · Paper page
- 10.1021/la048469l · DOI · Paper page
- 10.1002/adma.201402059 · DOI · Paper page
- 10.1517/17425247.2012.720969 · DOI · Paper page
- 10.1002/adma.200900383 · DOI · Paper page
- Chung PHY, 2017, A prospective interventional study to examine the effect of a silver alloy and hydrogel‐coated catheter on the incidence of catheter‐associated urinary tract infection, Hong Kong Med J, 23, 239
- 10.1016/j.urology.2010.04.039 · doi:10.1016/j.urology.2010.04.039
- 10.1021/cr020371t · DOI · Paper page
- 10.1021/bm701301s · DOI · Paper page
- 10.1089/end.2000.14.39 · doi:10.1089/end.2000.14.39
- 10.1021/am501961b · DOI
- 10.1002/anie.201304060 · DOI · Paper page
- 10.1021/acs.biomac.7b00100 · DOI
- 10.1021/acsami.7b07053 · DOI
- 10.1128/AAC.45.4.999-1007.2001 · DOI · Paper page
- 10.1016/j.jhin.2017.02.008 · DOI
- 10.3109/1040841X.2010.532479 · DOI · Paper page
- 10.1146/annurev.micro.55.1.165 · DOI · Paper page
- 10.1021/cr1000817 · DOI · Paper page
- Grossman AD, 1988, Extracellular control of spore formation in Bacillus subtilis, Proc Natl Acad Sci, 85, 4369, 10.1073/pnas.85.12.4369 · DOI · Paper page
- 10.1016/S0021-9258(20)88238-6 · DOI · Paper page
- 10.1086/498914 · DOI
- 10.1086/345879 · DOI · Paper page
- 10.1128/AAC.45.6.1930-1933.2001 · DOI
- 10.1128/AAC.01906-16 · DOI
- 10.1016/j.ijpharm.2015.02.067 · doi:10.1016/j.ijpharm.2015.02.067
- 10.1016/j.jbiotec.2010.12.016 · DOI
- 10.1111/j.1574-6976.2005.00012.x · DOI · Paper page
- 10.1021/acsami.5b09489 · DOI · Paper page
- 10.1007/s00253-015-6378-7 · DOI
- 10.1128/IAI.61.9.3879-3885.1993 · DOI · Paper page
- 10.1371/journal.ppat.1000052 · DOI · Paper page
- 10.1016/j.micpath.2013.07.003 · DOI
- 10.1172/JCI119473 · DOI · Paper page
- 10.1016/j.biomaterials.2005.05.017 · DOI · Paper page
- 10.1016/j.urology.2011.02.063 · DOI
- 10.1093/cid/cis639 · DOI
- 10.1016/j.urology.2011.03.062 · DOI
- 10.1016/j.jinf.2015.05.014 · DOI
- 10.1073/pnas.93.18.9827 · DOI · Paper page
- 10.1086/591093 · DOI
- 10.1111/j.1574-695X.2007.00296.x · doi:10.1111/j.1574-695x.2007.00296.x
- 10.1128/IAI.01730-06 · DOI
- 10.1111/j.1462-5822.2007.00912.x · DOI
- 10.1039/C5BM00076A · DOI
- 10.1016/j.biomaterials.2011.02.056 · DOI
- 10.1016/j.actbio.2017.01.011 · DOI
- 10.1016/j.actbio.2017.10.008 · DOI
- 10.1016/j.tibtech.2012.06.004 · DOI · Paper page
- 10.1111/j.1574-6968.2007.01012.x · DOI · Paper page
- 10.1007/s40820-015-0040-x · DOI · Paper page
- 10.1111/j.1750-3841.2008.01013.x · DOI · Paper page
- 10.1021/es802806n · DOI
- 10.1021/la704075r · DOI · Paper page
- 10.1289/ehp.8284 · DOI · Paper page
- 10.1093/toxsci/kfp188 · DOI · Paper page
- 10.1021/ar300040z · DOI · Paper page
- 10.1038/238037a0 · DOI · Paper page
- 10.1021/jp0502196 · DOI · Paper page
- 10.1002/jbm.b.30939 · DOI
- 10.1021/am506516r · DOI
- 10.1016/j.ijantimicag.2008.12.004 · DOI · Paper page
- 10.1007/s00284-010-9652-z · DOI
- 10.1385/ABAB:112:3:163 · DOI
- 10.1021/bp050198x · DOI · Paper page
- 10.1186/1471-2180-12-24 · DOI
- 10.1007/s00449-013-0976-5 · DOI
- 10.1021/nl102290k · DOI · Paper page
- 10.1116/1.4922157 · doi:10.1116/1.4922157
- 10.1021/acsami.7b16715 · DOI
- 10.1002/adma.201001215 · DOI · Paper page
- 10.1021/acsbiomaterials.7b00799 · DOI
Cited by
Lara, H. H., & Lopez-Ribot, J. L. (2020) · Pathogens · doi:10.3390/pathogens9100784 · Cited by 36
“Antimicrobial-coated catheters have been proposed to decrease the chances of acquiring a catheter-related bloodstream infection, and an attractive alternative is to prevent colonization and biofilm formation by coating biomaterials with biofilm inhibitors [34,35].”
BackgroundLima, M., Teixeira-Santos, R., Gomes, L. C., Faria, S. I., Valcarcel, J., Vázquez, J. A., Cerqueira, M. A., Pastrana, L., Bourbon, A. I., & Mergulhão, F. J. (2021) · Molecules · doi:10.3390/molecules26144378 · Cited by 30
Metadata
- Authors
- Zhu, Z., Wang, Z., Li, S., & Yuan, X.
- Affiliations
- School of Materials Science and Engineering Qingdao University of Science and Technology Qingdao Shandong 266042 China
- Shandong Peninsula Engineering Research Center of Comprehensive Brine Utilization Weifang University of Science and Technology Weifang Shandong 262700 China
- Department of Chemistry University of Houston Houston Texas 77204 USA
- Venue
- Journal of Biomedical Materials Research Part A
- Publisher
- Wiley
- Published
- 2018-11-23
- Volume
- 107
- Issue
- 2
- Pages
- 445-467
- ISSN
- 1549-3296
- 1552-4965
- Cited by
- 137
- References
- 8
- Language
- en
- Funders
- National Natural Science Foundation of China (31800800)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.